Want the short version?
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
NSRX · NYSE American · Pharmaceutical Preparations · Foreign private issuer
Nasus Pharma (NSRX) · oqro.io/stocks/NSRX · printed today. Every figure comes from a public filing, linked on the page online. Not investment advice.
$2.66−0.21 (−7.32%)
Close of Nov 16, 2026, vs Nov 13 · end-of-day, not a live quote
Everything reported about this company, newest first. Each line shows the dates that matter for its source.
Fund moves · Holdings as of Jun 30, 2026 (Q2 2026) · Filed Aug 14, 2026
Cable Car Capital, LP disclosed an increased position in NSRX for Q2 2026SourceInsider trade · Traded Jun 17, 2026 · Filed Jun 22, 2026
CEO purchased ~$20K of NSRX shares in the open marketSourceFund moves · Holdings as of Mar 31, 2026 (Q1 2026) · Filed May 15, 2026
Cable Car Capital, LP disclosed a new position in NSRX for Q1 2026SourceInsider trade · Traded Apr 22, 2026 · Filed Apr 23, 2026
CEO purchased ~$11K of NSRX shares in the open marketSourceInsider trade · Traded Mar 31, 2026 · Filed Apr 1, 2026
CEO purchased ~$31K of NSRX shares in the open marketSource